Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zooming in and out of ferroptosis in human disease
Xue Wang, Ye Zhou, Junxia Min, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 2, pp. 173-206
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 62
Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 55
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
Liang Tao, Xinquan Yang, Chaodong Ge, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2190-2206.e5
Open Access | Times Cited: 20
Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors
Carolina Punziano, Silvia Trombetti, Elena Cesaro, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 298-298
Open Access | Times Cited: 15
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Molecular mechanisms and clinical implications of the gold drug auranofin
Shuying Shen, Jie Shen, Zhong Luo, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215323-215323
Closed Access | Times Cited: 24
Hepatic HDAC3 Regulates Systemic Iron Homeostasis and Ferroptosis via the Hippo Signaling Pathway
Hongen Meng, Yingying Yu, Enjun Xie, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 23
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 13
Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Characterization of ferroptosis-triggered pyroptotic signaling in heart failure
Xukun Bi, Xiaotian Wu, Jiaqi Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Deciphering Epigenetic and Post-Translational Modifications in Ferroptosis: A Scientometric and Visualization Study
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 3, pp. 508-527
Open Access | Times Cited: 1
ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape
Tianyao Liu, Xinyan Xu, Jiazheng Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 19
Pollutants to pathogens: The role of heavy metals in modulating TGF-β signaling and lung cancer risk
Asif Ahmad Bhat, Ehssan Moglad, Pooja Bansal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155260-155260
Closed Access | Times Cited: 7
Application of natural products in regulating ferroptosis in human diseases
Liyan Deng, Wen Tian, Lianxiang Luo
Phytomedicine (2024) Vol. 128, pp. 155384-155384
Closed Access | Times Cited: 6
Global research landscape on the crosstalk between ferroptosis and musculoskeletal diseases: A bibliometric and visualized analysis
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e23113-e23113
Open Access | Times Cited: 14
Modulation of Metal Homeostasis for Cancer Therapy
Ying Yang, Huanhuan Fan, Zijian Guo
ChemPlusChem (2024) Vol. 89, Iss. 6
Closed Access | Times Cited: 5
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Astragaloside IV inhibits atherosclerosis caused by ferritin autophagy in a lipid deposition environment by activating Nrf2
Dandan Liu, Hewei Qin, Guanghua Liu, et al.
Journal of Functional Foods (2025) Vol. 126, pp. 106695-106695
Closed Access
Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Feng Zhang, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
Bibliometric and Graphical Analysis of Ferroptosis and Aging Research: Trends, Gaps, and Future Directions
Siyang Cao, Yingchen Pang, Yihao Wei, et al.
Pathology - Research and Practice (2025), pp. 155949-155949
Closed Access
Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor
Ruobing Liu, Juanjuan Wang, Yuqing Liu, et al.
Cancer Letters (2024) Vol. 598, pp. 217115-217115
Closed Access | Times Cited: 4
Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Adipocyte-derived ferroptotic signaling mitigates obesity
Xue Wang, Qian Wu, Minling Zhong, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 4
Silencing Ribosome biogenesis regulator 1 homolog (RRS1) inhibits angiogenesis and cisplatin resistance of lung cancer cells by activating ferroptosis mediated by p53 pathway
Ling Lin, Ying Zou, Di Zhang
Tissue and Cell (2025) Vol. 94, pp. 102796-102796
Closed Access
Page 1 - Next Page

Scroll to top